As of 31 Dec 2025, 1 institutional investors reported holding 26,383 shares of Merck & Co. - COM.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 26,383 | $2,777,053 | +$116,311 | $105.26 | 1 |
| 2025 Q3 | 25,278 | $2,121,567 | -$59,506 | $83.93 | 1 |
| 2025 Q2 | 25,987 | $2,057,121 | -$257,585 | $79.16 | 1 |
| 2025 Q1 | 29,241 | $2,624,667 | -$3,680 | $89.76 | 1 |
| 2024 Q4 | 29,282 | $2,912,980 | -$40,389 | $99.48 | 1 |
| 2024 Q3 | 29,688 | $3,371,362 | -$14,649 | $113.56 | 1 |
| 2024 Q2 | 29,817 | $3,691,397 | -$194,369 | $123.80 | 1 |
| 2024 Q1 | 31,387 | $4,141,579 | -$34,967 | $131.95 | 1 |
| 2023 Q4 | 31,652 | $3,450,706 | +$1,199 | $109.02 | 1 |
| 2023 Q3 | 31,641 | $3,257,411 | +$255,931 | $102.95 | 1 |
| 2023 Q2 | 29,155 | $3,364,193 | -$366,478 | $115.39 | 1 |
| 2023 Q1 | 32,331 | $3,439,666 | +$154,903 | $106.39 | 1 |
| 2022 Q4 | 30,875 | $3,425,624 | -$187,286 | $110.95 | 1 |
| 2022 Q3 | 32,563 | $2,804,000 | +$2,804,000 | $86.11 | 1 |